Precisely Where Are We Going? Charting the New Terrain of Precision Prevention

In addition to genetic data, precision medicine research gathers information about three factors that modulate gene expression: lifestyles, environments, and communities. The relevant research tools-epidemiology, environmental assessment, and socioeconomic analysis-are those of public health sciences rather than molecular biology. Because these methods are designed to support inferences and interventions addressing population health, the aspirations of this research are expanding from individualized treatment toward precision prevention in public health. The purpose of this review is to explore the emerging goals and challenges of such a shift to help ensure that the genomics community and public policy makers understand the ethical issues at stake in embracing and pursuing precision prevention. Two emerging goals bear special attention in this regard: (a) public health risk reduction strategies, such as screening, and (b) the application of genomic variation studies to understand and reduce health disparities among population groups.

Authors

Institutions

Publication Details

Journal
UNC Libraries
Published
2025-03-08
DOI
https://doi.org/10.17615/jw9a-pt64
Primary Topic
BRCA gene mutations in cancer
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention

Eric T. Juengst, Jennifer R. Fishman, Karen M. Meagher, Richard A. Settersten et al.
UNC Libraries
BRCA gene mutations in cancer
article

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention

Eric T. Juengst, Jennifer R. Fishman, Karen M. Meagher, Richard A. Settersten, Michelle L. McGowan
article en

Abstract

In addition to genetic data, precision medicine research gathers information about three factors that modulate gene expression: lifestyles, environments, and communities. The relevant research tools-epidemiology, environmental assessment, and socioeconomic analysis-are those of public health sciences rather than molecular biology. Because these methods are designed to support inferences and interventions addressing population health, the aspirations of this research are expanding from individualized treatment toward precision prevention in public health. The purpose of this review is to explore the emerging goals and challenges of such a shift to help ensure that the genomics community and public policy makers understand the ethical issues at stake in embracing and pursuing precision prevention. Two emerging goals bear special attention in this regard: (a) public health risk reduction strategies, such as screening, and (b) the application of genomic variation studies to understand and reduce health disparities among population groups.

UNC Libraries
University of North Carolina at Chapel Hill (US)
Openalex Percentile: Top 64%
BRCA gene mutations in cancer
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Precisely Where Are We Going? Charting the New Terrain of Precision Prevention — Eric T. Juengst, Jennifer R. Fishman, et al. · UNC Libraries (2025) | TGRS Research Map | TGRS